Nina Turner advocates for significant drug price reform. She believes pharmaceutical companies should not profit excessively from life-saving medications.
Key Policy Proposals
- Allowing the government to negotiate drug prices: Turner supports legislation enabling Medicare to negotiate lower prices with pharmaceutical companies, directly impacting millions of Americans. Ending patent extensions: She proposes limiting the duration of drug patents to prevent pharmaceutical companies from extending their monopolies and keeping prices artificially high. Increasing transparency in drug pricing: Turner pushes for greater transparency, allowing the public to understand the true cost of drug development and pricing strategies. Supporting the importation of lower-cost drugs: She actively supports policies that allow the importation of safe, FDA-approved drugs from other countries to create market competition and lower prices.
Impact of her Stance
These proposals aim to reduce drug costs, making life-saving medications more accessible to individuals and families. This would directly improve public health outcomes and alleviate the financial burden of prescription drugs on the American population.
Specific Examples
She’s cited the exorbitant cost of insulin as a prime example of the need for reform, advocating for affordable access to this life-saving medication. She regularly highlights cases where individuals struggle to afford necessary medications, emphasizing the human cost of high drug prices.
Her advocacy focuses on tangible policy changes designed to deliver immediate and lasting improvements in affordability and access to essential medicines.
